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Abstract Anaphylaxis is a severe and potentially life-threatening allergic
reaction that requires immediate treatment. A proposal for the development
of a mobile application for supporting anaphylaxis patients was written by
a team of allergists, after which this study was performed in order to
identify critical success factors for the adoption of such an app. A mixedmethod approach is used in order to gather data from a variety of sources,
comprising a literature review, a domain expert interview, and a patient
survey. One of the most valuable factors proved to be the validation of the
medical information provided in the app. Besides this, patients are mostly
concerned with the clarity of the presented information. While the proposed
app does not fulfill all the identified factors, its development is overseen by
medical professionals and endorsed by patient organizations. With a lack
of such apps in the Dutch market and the demand indicated by survey
respondents, this app has the potential to fill a gap in the support of
anaphylaxis patients.
Keywords: • Allergens • Anaphylaxis • Apps • Healthcare • Mobile •

CORRESPONDENCE ADDRESS: Koen Smit, Digital Smart Services, HU University of Applied
Sciences Utrecht, Nijenoord 1, 3552 AS Utrecht, The Netherlands, e-mail: koen.smit@hu.nl. Joris
Mens, HU University of Applied Sciences Utrecht, Nijenoord 1, 3552 AS Utrecht, The
Netherlands, e-mail: Joris.mens@hu.nl. Matthijs Berkhout, HU University of Applied Sciences
Utrecht ,Digital Smart Services, Nijenoord 1, 3552 AS Utrecht, The Netherlands, e-mail:
matthijs.berkhout@hu.nl.
https://doi.org/10.18690/978-961-286-043-1.39
© 2017 University of Maribor Press
Available at: http://press.um.si.

ISBN 978-961-286-043-1

562

30TH BLED ECONFERENCE: DIGITAL TRANSFORMATION – FROM CONNECTING THINGS TO
TRANSFORMING OUR LIVES (JUNE 18 – 21, 2017, BLED, SLOVENIA)
K. Smit, J. Mens & M. Berkhout: Developing a Mobile Application for Managing
Anaphylaxis: Discovering Critical Success Factors

Introduction
In this paper, we study a mobile application (app) for supporting anaphylaxis patients.
The app was proposed by a team from the department for allergology at the University
Medical Center Utrecht (UMCU), a large academic teaching hospital in the Netherlands.
The app will be developed in collaboration with physicians and patient groups supporting
anaphylaxis patients. Anaphylaxis is a type of immediate allergic reaction categorized as
type 1 hypersensitivity (Gell & Coombs, 1963), further defined as "... an acute, systemic
reaction caused by mast cell–mediator release [which is] potentially life threatening"
(Yocum et al., 1999). Anaphylaxis may be caused by a number of triggers, also called
anaphylaxis agents, such as foods, medication, insect bites or contact with latex (Kemp
& Lockey, 2002). Anaphylactic reactions cause symptoms which may be life-threatening
and require an emergency response (Schwartz, 1994). The proposed app is intended to
support anaphylaxis patients and their caregivers by providing step-by-step assistance in
the case of an anaphylactic reaction.
Exposure to allergens that cause anaphylactic reactions may occur via ingestion,
inhalation, injection or direct contact (WAO, 2012). Anaphylaxis manifests itself through
symptoms such as flushing and itchiness of the skin, difficulty breathing, swelling of the
mouth or eyes or an abnormal heart rate (Sampson et al., 2006). An anaphylactic reaction
is usually treated by administering a dose of epinephrine (adrenaline) intramuscularly
into the thigh using an auto-injector, after which the patient should be admitted to a
hospital for further treatment and observation (Sampson, 2003).
The exact prevalence of anaphylaxis is difficult to establish, as people may develop
sensitivities to allergens at different points in life, or may be unaware of sensitivities to
allergens they have not yet been exposed to. Different studies indicate a 0.5% to 2%
prevalence in the world's population (Simons, 2010), a 1.21% to 15.04% prevalence
(Neugut, Ghatak, & Miller, 2001) and a 1.6% to 7.7% prevalence in the US population
(Wood et al., 2014). Data provided in the app's proposal indicates the prevalence of
diagnosed food allergy in The Netherlands at 1-2% in adults and 1-3% in children, with
90% carrying emergency medication. For insect bites, the prevalence is 1-3% among the
Dutch population. The morbidity and mortality of anaphylaxis are believed to be
underestimated due to limited data on its incidence (Brown, McKinnon, & Chu, 2001;
Neugut et al., 2001). Evidence points towards an increase in anaphylaxis prevalence
(Liew, Williamson, & Tang, 2009), which may be attributed to changes in diet and
medicine use (Sheikh & Alves, 2000).
Besides the physical symptoms, anaphylaxis is shown to have a societal impact by leading
to a decreased quality of life and limiting of social activities for children (Sicherer,
Noone, & Munoz-Furlong, 2001), as well as proneness to school absence and decreased
participation in the labour market for adolescents (Marklund, Ahlstedt, & Nordström,
2007). Several patient groups aim to support anaphylaxis patients by providing
information on the internet. Examples are the National Foundation of Food Allergy (in
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Dutch: Stichting Voedselallergie) and the Dutch Anaphylaxis Network (in Dutch:
Nederlands Anafylaxie netwerk).
This study aims to determine the critical success factors for the adoption of the proposed
anaphylaxis app. To achieve this, we conducted a mixed method approach, containing a
literature review, a domain expert interview, and a patient survey. The research question
addressed in this paper is defined as follows:
RQ: “What are critical success factors for user acceptance of an app to support patients
suffering from severe allergic reactions?”
The remainder of this paper is organized as follows. First, we provide information with
regards to the anaphylaxis app that will be developed by UMCU, analyze similar apps
and identify (critical) success factors for the adoption of such apps in literature in the
background and related work section. This is followed by the research method in section
three. In section four, the results of the mixed method approach are presented. Lastly, in
section five, we reflect on the results and applied research methods in the discussion,
conclude upon our study, and propose possible directions for future research.
Background and related work
In this section, the anaphylaxis app will be presented and compared to existing
applications. Additionally, the literature with regards to Critical Success Factors (CSFs)
is explored and discussed upon.
2.1

The anaphylaxis app

The anaphylaxis app studied in this paper was proposed by a team at the department of
allergy at the UMCU. The proposal entails a request for funding, which will be needed
to start the development of the app for Android and iOS. Currently, no actual app or
prototype exists. Development of the app will be performed by the Medical Apps Cocreation Center, also known as MAC³. MAC³ provides centralized services for the
development, testing, and research of medical apps. The author of the proposal was
interviewed in order to gather background information on the app.
The team at UMCU collaborates with the National Foundation for Food Allergy, the
Dutch Anaphylaxis Network and the domain group for eczema, which is a part of the
Dutch Society of Dermatology and Venereology. These contacts are used to establish
requirements for the app and to foster its acceptance in the medical community.
The purpose of the app is to provide a better alternative compared to the leaflets that are
usually given to patients by physicians, alongside anaphylaxis medication. Such leaflets
provide information on emergency procedures but are not always carried by the patient.
The app should improve the availability of this information by residing on the
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smartphones of patients or caregivers. The information provided will be personalized
depending on the type of reaction (caused by food or insect bites), the severity of the
reaction and the medication the patient uses. Information on reactions caused by other,
less common triggers is not explicitly included, but may be covered by the available
information on treating reactions caused by food or insect bites.
Besides providing assistance in the case of an allergic reaction, the app will provide
background information on allergic reactions to be consulted at any time. While similar
apps already exist in countries such as the UK and Australia, an app geared towards the
Dutch market that is endorsed by patient organizations and contains validated medical
information and instructions is not yet available. Country-specific apps are also needed
because of differences in medications available per country.
2.2

Related apps/games

The current offering of anaphylaxis-related apps was studied in order to explore
similarities and differences compared to the proposed app. Apps were collected by
performing the search query: ‘Anaphylaxis’ and ‘Allergy’ on the Google Play Store and
the Apple App Store, including related apps for any identified app that resulted from our
search. The apps and their characteristics, features, and ratings are compared in Table 1.
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Name
Developer
Platform

Price
Install base
Target
market
Vendorspecific
General
informatio
n
Personalize
d
advice
Emergency
contacts
Expiry
reminders
Facility
Locator

Table 1: Related app comparison
Anaphylax Jext
Anaphylact Anaphylaxis1
is
ic Shock
01
Coventry
ALKSmall cog
Mylan
Univ.
Abelló
iOS,
iOS
Androi Android
iOS, Android
d
Free
Free
€ 1.16
Free
Unknown
10010-50
100-500
500
UK
UK
General
US
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Anaphylax
is Allergy
Phacia Inc.
iOS
$ 0.99
Unknown
US

No

Yes

No

No

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

Yes

Yes

No

No

Yes

Yes

Yes

No

No

No

Yes

No

No

No

Yes

Most apps provide similar functionalities, some being more extensive than others. Such
functionalities may include general information about anaphylaxis and allergies,
instructions for emergency procedures and the use of auto-injectors, medication
expiration reminders and interactive maps for finding nearby medical facilities. All apps
found are aimed at anaphylaxis patients or caregivers. As evidenced by the available data
on the number of installations, there does not appear to be one particularly popular
anaphylaxis app. Install base data is only available on the Google Play Store and not on
the Apple App Store. In terms of ratings and evaluations of the app, no information was
found originating from independent sources.
Some of the compared apps are free to use, while others require a small fee. Apps such
as the one made by Coventry University are intended for a more general audience of
anaphylaxis patients, while the Jext app developed by ALK-Abelló is to be used
specifically by patients using Jext-branded auto-injectors. The former app is also the only
app found that is endorsed by a local patient organization, namely the UK Anaphylaxis
Campaign.
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Critical success factors

The current body of knowledge on critical success factors in the context of this study
consists of research on both (mobile) allergy management in general and anaphylaxis
management. The available literature, which consisted of nine relevant papers, is
presented in three main categories; preventative information, providing assistance, and
mobile healthcare.
2.3.1

Preventative information

Mobile technology is used in several ways to support patients suffering from allergies or
anaphylaxis. One of these ways is providing preventative information by enabling
patients to scan food items or medications through the use of barcode or NFC technology.
A general study into smartphones and barcode scanning by Eichler & Luke (2009)
describes a prototype developed by Deutsche Telekom Laboratories called 'Allergy
Warner', which provides an alert message when scanning barcodes of food products in
the supermarket. The app will contain a personalized allergy profile which looks for
matching ingredients in the scanned products. Eicher & Luke argue that modern
smartphones can quickly and easily scan and recognize multiple types of barcodes,
making them suitable for this purpose.
A similar study by Gassner, Vollmer, Prehn, Fiedler, & Ssmoller (2005) concludes that
reliable information about food products is difficult to obtain because of different
interests of stakeholders in the food value chain. A mobile app that provides such
information would fill a gap in the market. Ottenhof (2010) provides a proof of concept
for a device-based solution (DBS) that allows customers in supermarkets to scan product
packages for allergy information. However, Ottenhof concludes that a lack of information
provided by manufacturers proves to be an obstacle. Stierman (2009) found that scanning
product packages make it easier for patients to retrieve allergen information. Patients
were more likely to buy products they were unfamiliar with thanks to a scanning solution.
A study by Möller, Diewald, Roalter, & Kranz (2012) evaluated an application called
MobiMed, which allows users to scan medicines in different ways, either through text
search, barcode scanning, visual search or Near Field Communication (NFC). This app
could then be used to warn patients for medicines that would put them at risk of allergic
reactions. Extracting information through NFC was found to be the fastest and most
preferable method because the user does not need to search for and scan a barcode.
However, the integration of NFC technology in smartphones and packaging is not yet
widespread.
Ottenhof (2010) found that NFC (or similarly, RFID) technology provides the best
matching capabilities because of its high storage capacity and the possibility to tag
products on an item level rather than by product type. While this information is easily
extracted by modern smartphones, the implementation of RFID/NFC on packaging is

30TH BLED ECONFERENCE: DIGITAL TRANSFORMATION – FORM CONNECTING THINGS TO
TRANSFORMING OUR LIVES (JUNE 18 – 21, 2017, BLED, SLOVENIA)
K. Smit, J. Mens & M. Berkhout: Developing a Mobile Application for Managing
Anaphylaxis: Discovering Critical Success Factors

567

relatively expensive. Scanning of standard EAN-13 barcodes is the cheapest in terms of
implementation since products are already equipped with these barcodes. However,
EAN-13 has a low storage capacity and can only identify products on a product level. A
backend that provides additional information would be needed. Problems could occur
when the composition of one type of product with the same barcode changes over time.
When looking at the current literature on providing preventative allergy information to
patients, we can conclude that there are still some improvements that can be made to cater
to patients. In terms of retrieving the information, a universal, fast and cost-effective
method needs to be found to provide contextual information about physical products on
a smartphone. Additionally, manufacturers of medicines and food products need to
provide allergen information that is easily accessible for consumers.
2.3.2

Providing assistance

A series of works by Hernandez et al. describes a personal mobile health device and the
associated app used to alert emergency services automatically when an auto-injector is
administered to a patient (Hernandez Munoz & Woolley, 2009, 2010; Hernandez Munoz,
Woolley, & Baber, 2008). The solution, called PervaLaxis, uses an accelerometer
connected to an auto-injector to detect its usage, which is signaled wirelessly to a
smartphone using Bluetooth. Emergency services can be contacted automatically through
the phone.
In a later study, PervaLaxis was further validated by involving patients (Hernandez
Munoz & Woolley, 2010). A pilot study was performed, after which the patient sample
was increased over time. Use case diagrams were used to test usability and determine
important success factors for the solution. These success factors are reported to be:
adrenaline injectors expiry alerts, an emergency support button, and adrenaline injection
sensing. Limitations identified for this solution were the reliability of the mobile phone
transmission and the accuracy of the injection sensor.
Other works suggest that instructions for providing assistance to patients should be
segmented towards different user groups. This may be done based on the age of the
patient and the number of years of experience they have with their illness. Further
personalization of the app could be of use here (Miles, Valovirta, & Frewer, 2006; Yu &
Ramani, 2006).
2.3.3

Mobile healthcare

Obiodu (2012) studied the top 500 medical apps in the Android market and concluded
that the majority of apps are designed for healthcare professionals, while it is plausible
that most end-users are patients rather than healthcare professionals. One significant
problem is that it is often unknown whether medical apps intended for patients provide
information that is validated by medical professionals (Haffey, Brady, & Maxwell, 2013).
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In practice, it is found that medical professionals are often not involved in the
development process of medical apps, or that there is a lack of validated sources available
in the app (Buijink, Visser, & Marshall, 2013; Rosser & Eccleston, 2011). Beyond this,
there are no obvious signs to distinguish medically validated apps from apps that have
not been validated, such as an international mark of quality. When an app does not offer
a diagnosis, treatment or cure, it cannot be classed as a medical device and will not be
subject to the thorough scrutiny of such medical devices. (McCartney, 2013) However,
the general information or advice provided by such a medical app may still cause harm
to the patient. An increasing number of apps published and the lack of an international
safeguard for monitoring medical apps undermines patient safety (Cook & Nolan, 2011;
McCartney, 2013; Visvanathan, Hamilton, & Brady, 2012).
2.3.4

Critical Success Factors

The literature contains 9 relevant contributions with regards to CSFs applicable in our
study. The CSFs of the app can be defined as follows:
1.
2.
3.

The information is context-aware through scanning of physical objects;
The information is easy to retrieve;
The information improves the user's understanding of the subject.

When looking at the ability of the app to provide assistance in the event of an allergic
reaction and general characteristics of mobile healthcare, the following success factors
were identified:
4.
5.
6.

The app should provide advice that is validated by medical professionals;
The app should provide advice that is tailored to the user's medicines;
The app should provide advice that is tailored to the characteristics of the user,
such as age or level of experience.

In Table 2, the critical success factors are linked to the papers from the literature review.
In the header row, the six CSFs identified earlier are transformed into keywords.
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Table 2: Meta-analysis regarding CFSs in the current body of knowledge
1.
2.
3.
4.
5.
6. UserContext Ease Understanding Validity Tailored sensitive
(Eichler &
✓
✓
Lüke, 2009)
(Gassner et al.,
✓
✓
2005)
(Ottenhof,
✓
✓
✓
2010)
(Stierman,
✓
2009)
(Möller et al.,
✓
2012)
(Hernandez
✓
✓
✓
Munoz et al.,
2008)
(Hernandez
✓
✓
✓
Munoz &
Woolley, 2010)
(Hernandez✓
✓
✓
✓
Munoz &
Woolley, 2013)
(Miles et al.,
✓
✓
2006)
(Yu & Ramani,
✓
✓
2006)
Research method
3.1

Interview

In this section, we describe the setup, deployment and the evaluation of the interview
with a domain expert who is a representative and the founder of the Dutch Anaphylaxis
Network, known as NAN in Dutch. The NAN informs and provides support to patients
while also keeping in touch with stakeholders, such as food producers, on current issues
surrounding allergies.
As the interview is semi-structured of nature, the following topics are discussed:
1.
2.
3.
4.

The current necessity of an app;
Existing knowledge on mobile applications concerning allergy or anaphylactic
patients;
Critical success factors concerning user acceptance of an app;
Additional comments or advice.
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With regards to CSFs, the domain expert was first invited to provide his own insight into
possible CSFs and then asked to evaluate the CSFs identified during the literature review.
This was done in order not to create a possible bias by first presenting our findings derived
from literature.
3.2

Survey

Following the literature review and domain expert interview, a survey was conducted
among a sample of patients in order to gather further data on CSFs. As described in
section one, the proposed app is aimed at the Dutch market, with a prevalence of
diagnosed food allergy at 1-2% in adults and 1-3% in children, with 90% carrying
emergency medication. For insect bites, the prevalence is 1-3% among the Dutch
population, as indicated by the proposal of the app. All patients in The Netherlands who
may be at risk for anaphylactic shock are included in the scope of the survey.
The survey was designed to first establish basic information about the patient, such as
their age and the number of years of experience they have with anaphylaxis. The patient
was also asked if they are familiar with smartphones, including the total years of use and
a self-assessed competency rating. A number of possible functionalities for the app were
presented to the participants, for which they could indicate their desire for such a
functionality in an anaphylaxis app on a Likert scale. These functionalities were adopted
and where needed adapted from results of the literature review and domain expert
interview. An open-ended question provided respondents the possibility to provide
additional functionalities. The ratings given for the functionalities were then used to
determine the most valuable functionalities and therefore CSFs for the adoption of the
app. Another set of questions adopted from the System Usability Scale (SUS) and
Technology Acceptance Model (TAM) determined which usability factors were deemed
most important by patients, such as the clarity of the presented information and the
interactivity of the app. Finally, the respondents were asked to rate the likeliness of using
an anaphylaxis app on a scale of 1 to 10.
Results
In this section, the results of the interview and the patient survey are presented.
4.1

Domain expert interview

The domain expert was positive about the concept of an anaphylaxis app. There is a
necessity for such a solution in the domain. With regard to replacing paper leaflets, an
app may be useful, but only until the patient has familiarized himself with the
information. After this, the app will need additional functionalities to engage and support
the patient, such as training users to identify and avoid possible anaphylactic triggers.
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The domain expert identified the following CSFs for the adoption of an anaphylaxis app:
1.
2.

3.

4.
5.

4.2

The app should focus on including avoidance strategies for potential
anaphylactic triggers.
The app should include gamification, such as a quiz used to test knowledge on
allergens and emergency procedures, both for the patient, caregivers as well as
friends or family.
The app should focus on different user groups since the information needs of
each group can differ. Adolescents may more easily ignore food warnings, for
example, making it necessary to address them in a different way.
The app should be interactive, rather than just providing static content.
The app should be free. Earlier research by the domain expert concluded that
paid-for apps lead to low adoption rates among patients.
Patient Survey

Contacting patients directly through UMCU proved to be difficult and time-consuming
due to the clearance procedures involved. The decision was therefore made to deploy the
survey on the website of the NAN, with help of the domain expert interviewed earlier.
The NAN receives about 500 unique visitors per day on their website. The survey was
featured on the front page for a period of 6 days between from the 21st up until the 26th
of June 2014. Patients could voluntarily and anonymously fill out the survey on the
website.
276 respondents filled out the survey. The sample consists out of 16.7% male and 79.7%
female respondents (3.6% unknown), with an average age of 40.96 years (s = 11.17). Our
respondents have an average of 9.81 years of experience with anaphylaxis (s = 7.514).
93.1% of respondents indicate owning a smartphone. With a 46% percent share, Android
is the most used mobile operating system, closely followed by iOS at 39.1%. The
remaining share goes to other or unknown operating systems (13.8%) and Blackberry
(1.1%). The average number of years respondents have been using a smartphone is 3.95
years (s = 2.511). They rate their own competency in the use of mobile phones with a
7.75 (s = 1.797) on a scale of 1 to 10.
The desirability of an app to support anaphylaxis patients is rated with an average of 8.34
on a scale of 1 to 10 (s = 1.787), while the probability of the respondents using such an
app is rated with an 8.75 (s = 1.903). The three most compelling app features indicated
by respondents are the clarity of the information, the medical validation of the
information, and the availability of information regarding emergency procedures, with
average scores of 6.68, 6.62 and 6.48 on a scale of 1 to 7, respectively. The aspect rated
as least important are the presence of an element of play (gamification), a quiz to test
allergy knowledge and interactivity of the app, with average scores of 2.66, 3.33 and 4.50,
respectively. All CSFs are shown in table 3.
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Table 3: Survey results
N

Mis
sing

Me
an

Std.
Deviation

The app must present the information in an organized
manner
The app must have a medical validation of the provided
information
The app must scan product barcodes for information

274

2

6.68

0.651

275

1

6.62

0.799

273

3

6.48

0.944

The app must give information about emergency
procedures
The app must have a list of predefined emergency
contacts
The app must give advice about allergy triggers

274

2

6.48

0.999

275

1

6.43

1.038

276

0

6.31

1.328

The app must give advice about the expiration date of
the medicine
The app must give guidance for recognizing products
with specific ingredients
The app must have guidance for recognizing specific
ingredients
The app must give advice about the used medicine

274

2

6.18

1.23

275

1

6.11

1.35

276

0

6.03

1.366

276

0

6.03

1.373

The app must be free of charge

274

2

5.48

1.781

The app must be able to share my allergy information
with my surroundings
The app must look attractive

276

0

5.34

1.799

276

0

5.03

1.523

The app must show basic information about allergies

273

3

4.73

1.953

The app must be interactive

274

2

4.5

1.895

A quiz to test the knowledge about allergies

273

3

3.33

1.827

The app needs a challenging game element
(gamification)

274

2

2.66

1.694

The open-ended question in the survey asking patients for other desirable functionalities
yielded many results. The functionalities provided were categorized by similarity. 22
respondents indicated the desire for a functionality that helps to translate allergens and
emergency instructions into another language for when the patient is traveling. 12
respondents wish for an alarm button that can quickly contact emergency services and
other predefined contacts, and another 12 respondents wish for a newsfeed containing
updates on medication or treatments.
Conclusion & Discussion
The research questions addressed in this paper was defined as follows: What are the
critical success factors for user acceptance of an app to support patients suffering from
allergies? To answer this research question, we looked at the results of the analysis of the
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current body of knowledge, the domain expert interview and the patient survey that were
performed during this study. The various factors gathered from different sources indicate
that a broad range of features is possible in an app that supports anaphylaxis patients.
However, different features may appeal to different subgroups of patients depending on
the severity of their symptoms, their age, and experience with their illness, among other
factors.
In literature, a number of studies were found concerning food allergies in general and
specific measures for anaphylaxis. The studies on food allergies noted the possibility to
scan food packaging as a critical success factor for user adoption in their specific context.
The studies related specifically to anaphylaxis, such as the study concerned with
automatically detecting the activation of an adrenaline injector through a Bluetooth
accelerometer, were more concerned with the validity of the information provided by the
accompanying app. However, the UMCU has already indicated that such features will
not be included in the app at this time. The factors that remain, based on literature, are
that the app should contain medically validated information, be easy to use and improve
the user's understanding of the subject, and be sensitive to different user groups. The
proposed app will adhere to these factors.
The domain expert indicated a number of new factors mainly relating to the interactivity
of the app and having certain quiz or gamification elements that test the knowledge and
train them to avoid allergens. Another factor mentioned was that the app should be free
in order to boost user adoption. Patients surveyed agreed with this, although they did not
appear to be very enthusiastic about gamification or quizzes. Once more, new factors
were introduced after the patient survey such as the ability to translate allergens and
procedure information, providing a newsfeed and a list of predefined emergency contacts.
The factors for the medical validation of the information and the availability of clear
emergency procedures were also rated highly by patients. Another interesting factor is
that patients indicated they would overall be very likely to use such an app.
In relation to all of the features that were established in this study, the proposed
anaphylaxis app appears to be relatively limited in features. However, the team at UMCU
has indicated that the proposed app should be simple and straightforward to use. The
decision was made not to include features such as scanning of objects or giving extensive
information on types of food that contain allergens. Even though the app does not contain
all functionalities that may be seen as critical success factors, the app may still prove to
be of added value for patients when its functionalities are fit for purpose. The simplicity
of the app will also contribute to the clarity of the information, which was another success
factor.
An effectiveness study will have to reveal the actual usefulness of the app for patients.
The current body of knowledge related specifically to anaphylaxis apps is rather small
and anaphylaxis apps are a relative niche market within the medical app landscape,
making it difficult to predict the effects the CSFs will have on actual user adoption.
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Beyond this, we recommend the team at UMCU looks into the possible expansion of the
app in the future, in order to include some of the features that were indicated as being
desirable for patients. Moreover, our results also indicate a selection of lower rated
functionalities for the app. For example, the functionality that was rated lowest in our
results was the functionality regarding the addition of a challenging game element
(gamification). While we believe that our survey was conducted with the aim to gather
data from the appropriate user groups, some of the respondents indicated to be a parent
or caregiver. This is usually the case with younger children. There could be a difference
between how a sample drawn solely from patient groups versus our sample rate the
functionalities presented in a survey. Currently, our results are difficult to link with the
existing body of knowledge as no uniform opinion exists on the importance of CSFs and
related functionalities.
Besides the methods used in this study, further validation should be performed using
other patient organizations, medical professionals, domain experts, and patients. In this
study, we were only able to contact one medical professional (the author of the proposal
for the development of the app) and one representative of a patient organization (the
domain expert). Therefore, the results of the survey could be affected by the input from
the results of the interview, which were derived from one subject-matter expert. The
generalizability of our results could be improved by involving more subject-matter
experts from different perspectives (i.e. medical specialties, medical informatics, and
academics). In addition to the Dutch market, the development team could also get into
contact with other international organizations who have previously developed similar
apps in order to find out more about their lessons learned.
All in all, we believe that the current potential success of the app lies in the fact that it is
being developed by medical professionals in collaboration with patient organizations,
which is a highly regarded success factor. In addition, the app will be available for free
and is targeted towards the Dutch market, where no such app currently exists. The
information given about emergency procedures may indeed prove to be a useful
replacement to paper leaflets, once doctors start prescribing the app alongside
anaphylaxis medications. From a theoretical perspective, our study provides an overview
of CSFs and the importance of those CSFs in the context of a substantial Dutch sample
geared towards the development of an app to manage anaphylaxis. From a practical
perspective, our results provide direct evidence and directions for development and help
in the prioritization of the development of functionalities in similar apps.

References
Brown, a F., McKinnon, D., & Chu, K. (2001). Emergency department anaphylaxis: A review of
142 patients in a single year. The Journal of Allergy and Clinical Immunology, 108(5), 861–6.
https://doi.org/10.1067/mai.2001.119028

30TH BLED ECONFERENCE: DIGITAL TRANSFORMATION – FORM CONNECTING THINGS TO
TRANSFORMING OUR LIVES (JUNE 18 – 21, 2017, BLED, SLOVENIA)
K. Smit, J. Mens & M. Berkhout: Developing a Mobile Application for Managing
Anaphylaxis: Discovering Critical Success Factors

575

Buijink, A. W. G., Visser, B. J., & Marshall, L. (2013). Medical apps for smartphones: lack of
evidence undermines quality and safety. Evidence-Based Medicine, 18(3), 90–2.
https://doi.org/10.1136/eb-2012-100885
Cook, T. M., & Nolan, J. P. (2011). Use of capnography to confirm correct tracheal intubation
during cardiac arrest. Anaesthesia, 66(12), 1183–4. https://doi.org/10.1111/j.13652044.2011.06964.x
Eichler, G., & Lüke, K. (2009). Barcode Application Innovation for Smartphones. GI Jahrestagung,
5.
Gassner, K., Vollmer, G., Prehn, M., Fiedler, M., & Ssmoller, S. (2005). Smart Food: Mobile
Guidance for Food-Allergic People. In Seventh IEEE International Conference on ECommerce
Technology
(CEC’05)
(pp.
531–534).
IEEE.
https://doi.org/10.1109/ICECT.2005.85
Gell, P., & Coombs, R. (1963). Clinical aspects of immunology. Clinical Aspects of Immunology.
Haffey, F., Brady, R. R. W., & Maxwell, S. (2013). A comparison of the reliability of smartphone
apps for opioid conversion. Drug Safety : An International Journal of Medical Toxicology and
Drug Experience, 36(2), 111–7. https://doi.org/10.1007/s40264-013-0015-0
Hernandez-Munoz, L., & Woolley, S. (2013). Mobile Phone Tools with Ambient Intelligence for
the Management of Life-Threatening Allergies. … Aspects in Ambient Intelligence, 8, 153–
173. https://doi.org/10.2991/978-94-6239-018-8
Hernandez Munoz, L. U., & Woolley, S. I. (2009). A user-centered mobile health device to manage
life-threatening anaphylactic allergies and provide support in allergic reactions. In 2009 9th
International Conference on Information Technology and Applications in Biomedicine (pp. 1–
4). IEEE. https://doi.org/10.1109/ITAB.2009.5394347
Hernandez Munoz, L. U., & Woolley, S. I. (2010). A Personal Handheld Device to Support People
with Life-Threatening Anaphylactic Allergies (PervaLaxis). International Journal of Handheld
Computing Research, 1(1), 64–78. https://doi.org/10.4018/jhcr.2010090904
Hernandez Munoz, L. U., Woolley, S. I., & Baber, C. (2008). A mobile health device to help people
with severe allergies. In 2008 Second International Conference on Pervasive Computing
Technologies
for
Healthcare
(pp.
8–10).
IEEE.
https://doi.org/10.1109/PCTHEALTH.2008.4571012
Kemp, S. F., & Lockey, R. F. (2002). Anaphylaxis: A review of causes and mechanisms. Journal
of
Allergy
and
Clinical
Immunology,
110(3),
341–348.
https://doi.org/10.1067/mai.2002.126811
Liew, W. K., Williamson, E., & Tang, M. L. K. (2009). Anaphylaxis fatalities and admissions in
Australia. The Journal of Allergy and Clinical Immunology, 123(2), 434–42.
https://doi.org/10.1016/j.jaci.2008.10.049
Marklund, B., Ahlstedt, S., & Nordström, G. (2007). Food hypersensitivity and quality of life.
Current
Opinion
in
Allergy
and
Clinical
Immunology,
7(3),
279–87.
https://doi.org/10.1097/ACI.0b013e32814a569b
McCartney, M. (2013). How do we know whether medical apps work? BMJ, 1811(March), 1–2.
https://doi.org/10.1136/bmj.f1811
Miles, S., Valovirta, E., & Frewer, L. (2006). Communication needs and food allergy: a summary
of
stakeholder
views.
British
Food
Journal,
108(9),
795–802.
https://doi.org/10.1108/00070700610688412
Möller, A., Diewald, S., Roalter, L., & Kranz, M. (2012). MobiMed: comparing object
identification techniques on smartphones. In Proceedings of the 7th Nordic Conference on
Human-Computer Interaction Making Sense Through Design - NordiCHI ’12 (p. 31). New
York, New York, USA: ACM Press. https://doi.org/10.1145/2399016.2399022

576

30TH BLED ECONFERENCE: DIGITAL TRANSFORMATION – FROM CONNECTING THINGS TO
TRANSFORMING OUR LIVES (JUNE 18 – 21, 2017, BLED, SLOVENIA)
K. Smit, J. Mens & M. Berkhout: Developing a Mobile Application for Managing
Anaphylaxis: Discovering Critical Success Factors

Neugut, A. I., Ghatak, A. T., & Miller, R. L. (2001). Anaphylaxis in the United States. Archives of
Internal Medicine, 161(1), 15. https://doi.org/10.1001/archinte.161.1.15
Obiodu, V. (2012). An Empirical Review of the Top 500 Medical Apps in a European Android
Market.
Journal
of
Mobile
Technology
in
Medicine,
1(4),
22–37.
https://doi.org/10.7309/jmtm.74
Ottenhof, R. (2010). User-friendly mobile allergy checks: Providing allergy information about food
products. University of Amsterdam.
Rosser, B. a, & Eccleston, C. (2011). Smartphone applications for pain management. Journal of
Telemedicine and Telecare, 17(6), 308–12. https://doi.org/10.1258/jtt.2011.101102
Sampson, H. (2003). Anaphylaxis and emergency treatment. Pediatrics, (111), 1601–1608.
https://doi.org/10.1542/peds.111.6.S2.1601
Sampson, H., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., …
Decker, W. W. (2006). Second symposium on the definition and management of anaphylaxis:
summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and
Anaphylaxis Network symposium. The Journal of Allergy and Clinical Immunology, 117(2),
391–7. https://doi.org/10.1016/j.jaci.2005.12.1303
Schwartz, H. J. (1994). Anaphylaxis: A Potentially Fatal, Avoidable, and Often Ignored Clinical
Problem. Mayo Clinic Proceedings, 69(1), 93. https://doi.org/10.1016/S0025-6196(12)61622X
Sheikh, A., & Alves, B. (2000). Hospital admissions for acute anaphylaxis: time trend study. BMJ,
320, 1441.
Sicherer, S. H., Noone, S. A., & Munoz-Furlong, A. (2001). The impact of childhood food allergy
on quality of life. Annals of Allergy, Asthma, & Immunology, 87(6), 461–464.
Simons, F. E. R. (2010). World Allergy Organization survey on global availability of essentials for
the assessment and management of anaphylaxis by allergy-immunology specialists in health
care settings. Annals of Allergy, Asthma & Immunology : Official Publication of the American
College
of
Allergy,
Asthma,
&
Immunology,
104(5),
405–12.
https://doi.org/10.1016/j.anai.2010.01.023
Stierman, A. (2009). Barcode reading to determine allergens in food products. University of
Amsterdam.
Visvanathan, a, Hamilton, A., & Brady, R. R. W. (2012). Smartphone apps in microbiology--is
better regulation required? Clinical Microbiology and Infection: The Official Publication of the
European Society of Clinical Microbiology and Infectious Diseases, 18(7), 18–20.
https://doi.org/10.1111/j.1469-0691.2012.03892.x
WAO. (2012). WAO White Book on Allergy 2011-2012.
Wood, R. A., Camargo, C. A., Lieberman, P., Sampson, H. A., Schwartz, L. B., Zitt, M., … Simons,
F. E. R. (2014). Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in
the United States. The Journal of Allergy and Clinical Immunology, 133(2), 461–7.
https://doi.org/10.1016/j.jaci.2013.08.016
Yocum, M. W., Butterfield, J. H., Klein, J. S., Volcheck, G. W., Schroeder, D. R., & Silverstein,
M. D. (1999). Epidemiology of anaphylaxis in Olmsted County: A population-based study.
Journal of Allergy and Clinical Immunology, 104(2), 452–456. https://doi.org/10.1016/S00916749(99)70392-1
Yu, W., & Ramani, A. (2006). Design and Implementation of a Personal Mobile Medical Assistant.
Information Technology in Healthcare, 4(2), 92–102.

